Showing 1 - 5 results of 5 for search 'Jeffrey W. Tyner', query time: 0.02s
Refine Results
-
1
Immune cell proportions correlate with clinicogenomic features and ex vivo drug responses in acute myeloid leukemia by Kyle A. Romine, Daniel Bottomly, Daniel Bottomly, William Yashar, William Yashar, Nicola Long, Nicola Long, Matthew Viehdorfer, Shannon K. McWeeney, Shannon K. McWeeney, Jeffrey W. Tyner, Jeffrey W. Tyner
Published 2023-06-01
Article -
2
-
3
Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib by Myles Vigoda, Chase Mathieson, Nathaniel Evans, Carolyn Hale, Jennifer Jennings, Olivia Lucero, Sophia Jeng, Daniel Bottomly, Daniel Clayburgh, Peter Andersen, Ryan Li, Daniel Petrisor, Jeffrey W. Tyner, Shannon McWeeney, Molly Kulesz-Martin
Published 2022-12-01
Article -
4
Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia by Ryan J. Summers, Juhi Jain, Eleana Vasileiadi, Brittany Smith, Madison L. Chimenti, Tsz Y. Yeung, James Kelvin, Xiaodong Wang, Stephen V. Frye, H. Shelton Earp, Jeffrey W. Tyner, Erik C. Dreaden, Deborah DeRyckere, Douglas K. Graham
Published 2022-12-01
Article -
5
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia by Brian S. White, Suleiman A. Khan, Mike J. Mason, Muhammad Ammad-ud-din, Swapnil Potdar, Disha Malani, Heikki Kuusanmäki, Brian J. Druker, Caroline Heckman, Olli Kallioniemi, Stephen E. Kurtz, Kimmo Porkka, Cristina E. Tognon, Jeffrey W. Tyner, Tero Aittokallio, Krister Wennerberg, Justin Guinney
Published 2021-07-01
Article